DK3038596T3 - Sammensætninger og fremgangsmåder til fjernelse af tatoveringer - Google Patents

Sammensætninger og fremgangsmåder til fjernelse af tatoveringer Download PDF

Info

Publication number
DK3038596T3
DK3038596T3 DK14838935.6T DK14838935T DK3038596T3 DK 3038596 T3 DK3038596 T3 DK 3038596T3 DK 14838935 T DK14838935 T DK 14838935T DK 3038596 T3 DK3038596 T3 DK 3038596T3
Authority
DK
Denmark
Prior art keywords
tattoo
procedures
compositions
removal
Prior art date
Application number
DK14838935.6T
Other languages
English (en)
Inventor
Alec Guy Falkenham
Original Assignee
Univ Dalhousie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Univ Dalhousie filed Critical Univ Dalhousie
Application granted granted Critical
Publication of DK3038596T3 publication Critical patent/DK3038596T3/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/55—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/14—Liposomes; Vesicles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
    • A61K8/4973—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with oxygen as the only hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q1/00—Make-up preparations; Body powders; Preparations for removing make-up
    • A61Q1/14—Preparations for removing make-up
    • A61Q1/145—Tattoo removal

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Birds (AREA)
  • Epidemiology (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
DK14838935.6T 2013-08-30 2014-08-28 Sammensætninger og fremgangsmåder til fjernelse af tatoveringer DK3038596T3 (da)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201361871929P 2013-08-30 2013-08-30
PCT/CA2014/000663 WO2015027328A1 (en) 2013-08-30 2014-08-28 Compositions and methods for the removal of tattoos

Publications (1)

Publication Number Publication Date
DK3038596T3 true DK3038596T3 (da) 2020-04-06

Family

ID=52585331

Family Applications (1)

Application Number Title Priority Date Filing Date
DK14838935.6T DK3038596T3 (da) 2013-08-30 2014-08-28 Sammensætninger og fremgangsmåder til fjernelse af tatoveringer

Country Status (9)

Country Link
US (5) US9801799B2 (da)
EP (1) EP3038596B1 (da)
AU (1) AU2014311225B2 (da)
BR (1) BR112016004372B1 (da)
CA (1) CA2921762C (da)
DK (1) DK3038596T3 (da)
ES (1) ES2782360T3 (da)
PT (1) PT3038596T (da)
WO (1) WO2015027328A1 (da)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2997949A1 (en) * 2015-09-11 2017-03-16 Rxi Pharmaceuticals Corporation Methods for treating skin disorders and conditions utilizing haptens
HK1251188A1 (zh) * 2015-10-30 2019-01-25 达布尼专利有限责任公司 淡化和去除纹身的系统、设备和方法
EP3284505B1 (de) 2016-08-18 2019-03-27 nolax AG Verfahren zum entfernen von tätowierungen und verwendung eines microneedle-patches in einem verfahren zum entfernen von tätowierungen
RU2722455C1 (ru) * 2020-01-28 2020-06-01 Марина Леонидовна Тынянова Способ удаления татуировок у человека и композиция для его осуществления

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5540934A (en) 1994-06-22 1996-07-30 Touitou; Elka Compositions for applying active substances to or through the skin
GB9620504D0 (en) * 1996-10-02 1996-11-20 Boehringer Ingelheim Ltd Compositions
US20100146256A1 (en) 2000-01-06 2010-06-10 Super Talent Electronics Inc. Mixed-Mode ROM/RAM Booting Using an Integrated Flash Controller with NAND-Flash, RAM, and SD Interfaces
GB0118517D0 (en) 2001-07-30 2001-09-19 Mitsubishi Tokyo Pharm Inc Compound
AU2004220465A1 (en) 2003-03-13 2004-09-23 3M Innovative Properties Company Method of tattoo removal
US20050201959A1 (en) * 2004-03-11 2005-09-15 Vvii Newco 2003, Inc. Methods and compositions for altering skin coloration
CA2565079A1 (en) * 2004-05-06 2005-11-17 Merck & Co., Inc. Methods for treating arthritic conditions in dogs
US8187621B2 (en) 2005-04-19 2012-05-29 Advanced Cardiovascular Systems, Inc. Methods and compositions for treating post-myocardial infarction damage
US20070088414A1 (en) 2005-05-25 2007-04-19 Campbell Robert L Particulate formulations for intradermal delivery of biologically active agents
US20070081962A1 (en) 2005-10-06 2007-04-12 Amit Munshi Novel delivery of immune response modifiers for removal of chronic tattoos
US20070218116A1 (en) * 2006-03-14 2007-09-20 Schwendener Reto A Compositions and methods for the treatment of tumors and tumor metastases
EP2352543B1 (en) 2008-12-04 2019-04-03 BioChemics, Inc. Methods and compositions for tattoo removal
WO2010143193A1 (en) 2009-06-11 2010-12-16 Yissum Research Development Company Of The Hebrew University Of Jerusalem, Ltd. Targeted liposomes comprising n-containing bisphosphonates and uses thereof
US8637569B2 (en) * 2009-10-22 2014-01-28 Api Genesis, Llc Methods of increasing solubility of poorly soluble compounds and methods of making and using formulations of such compounds
EP2363111A1 (en) * 2010-03-01 2011-09-07 Combino Pharm, S.L. Stable pharmaceutical composition comprising bisphosphonate
WO2011132826A1 (en) * 2010-04-19 2011-10-27 Snu R&Db Foundation Transdermal drug delivery system and pharmaceutical composition for preventing or treating bone diseases
WO2011159951A2 (en) * 2010-06-17 2011-12-22 Sanford-Burnham Medical Research Institute Targeting tumor associated macrophages using bisphosphonate-loaded particles
US20120310140A1 (en) * 2010-12-01 2012-12-06 Spinal Modulation, Inc. Directed delivery of agents to neural anatomy
JP5864615B2 (ja) * 2011-01-25 2016-02-17 ザ プロクター アンド ギャンブルカンパニー リポソーム及びそれを含むパーソナルケア組成物
US9993427B2 (en) * 2013-03-14 2018-06-12 Biorest Ltd. Liposome formulation and manufacture

Also Published As

Publication number Publication date
US10105302B2 (en) 2018-10-23
AU2014311225B2 (en) 2019-12-19
US12226508B2 (en) 2025-02-18
NZ717166A (en) 2021-05-28
EP3038596A4 (en) 2017-02-08
BR112016004372B1 (pt) 2021-01-05
AU2014311225A1 (en) 2016-03-10
EP3038596B1 (en) 2020-01-08
EP3038596A1 (en) 2016-07-06
CA2921762A1 (en) 2015-03-05
US20190008744A1 (en) 2019-01-10
WO2015027328A1 (en) 2015-03-05
US20160279045A1 (en) 2016-09-29
US20250161183A1 (en) 2025-05-22
CA2921762C (en) 2022-07-12
US9801799B2 (en) 2017-10-31
US20220257489A1 (en) 2022-08-18
ES2782360T3 (es) 2020-09-14
PT3038596T (pt) 2020-04-03
US20170042781A1 (en) 2017-02-16
US11344490B2 (en) 2022-05-31

Similar Documents

Publication Publication Date Title
DK3008168T3 (da) Sc-celler og sammensætninger og fremgangsmåde til dannelse deraf
DK3035926T3 (da) Forbindelser og fremgangsmåder til behandling af en epilepsilidelse
DK3007695T3 (da) Sammensætninger og fremgangsmåder til behandling af anæmi
DK3556869T3 (da) Sammensætninger og fremgangsmåder til sekventering af polynukleotider
IL247777B (en) Ablation catheter and ablation apparatus
DK3102673T3 (da) Fremgangsmåder og sammensætninger til behandling af beta-talassæmi
DK3080100T3 (da) Hæmmere af lysinspecifik demethylase-1
DK3119797T3 (da) Raav-baserede sammensætninger og fremgangsmåder til behandling af amyotrofisk lateralsklerose
DK3594348T3 (da) Kort c/ebp-alpha til aktivering af rna-sammensætninger og anvendelsesfremgangsmåder
HRP20180817T1 (hr) Sastavi i postupci za modulaciju farnesoid-x-receptora
DK3685848T3 (da) Sammensætninger og fremgangsmåder til behandling af pulmonal hypertension
DK2968208T3 (da) Behandling af kataplexi
DK2991656T3 (da) Sammensætninger og fremgangsmåder til modulering af apolipoprotein c-iii-ekspression
DK2983787T3 (da) Fremgangsmåde til behandling af posttraumatisk stresssygdom
DK3144001T3 (da) Sammensætninger af selenoorganiske forbindelser og fremgangsmåder til anvendelse deraf
DK3083683T3 (da) Sammensætninger og fremgangsmåder til behandling af fedtvævsansamlinger
DK2994533T3 (da) Fremgangsmåder og sammensætninger til behandling af cancer
DK3366307T3 (da) Sammensætninger og fremgangsmåder til inhibering af masp-1 og/eller masp-3 til behandling af paroxystisk nokturn hæmoglobinuri
DK3050883T3 (da) Fremgangsmåde til fremstilling af diazabicyclooctanderivater og mellemprodukter
DK3238707T3 (da) Sammensætninger og fremgangsmåder til behandling af intestinal hyperpermeabilitet
DK3025586T3 (da) Sammensætning til bekæmpelse af plantesygdomme og anvendelse deraf
DK3363805T3 (da) Fremgangsmåder til syntese af sphingomyeliner og dihydrosphingomyeliner
DK2994157T3 (da) Tafa4-forbindelser og anvendelser deraf til behandling af smerte
DK3077467T3 (da) Sikkativsammensætning og anvendelse deraf
DK2964767T3 (da) Toksingener og fremgangsmåder til anvendelse deraf